Invacare Showcases new Robin EVO at The OT Show 2025

News

Invacare Showcases new Robin EVO at The OT Show 2025

Invacare exhibits at The OT Show 2025 NEC Birmingham

Invacare, a leader in Safe Patient Handling and Pressure Area Care products, is set to exhibit at The OT Show taking place at the NEC Birmingham on 26 & 27 November 2025.

The company will unveil its latest product innovation in patient transfers with the new Robin EVO overhead hoist at Stand E50, alongside live demonstrations on stand and opportunities to meet its team of experts.

This event is a two-day conference and exhibition programme designed for Occupational Therapists working in healthcare environments from social care services, housing, voluntary organisation as well as independent practitioners. The OT Show makes it easier for OTs to find new and updated information and resources to support their everyday work.

“We’re thrilled to be at The OT Show this year to launch the next evolution in patient transfer with our new Robin EVO.  The OT show is an important event to showcase our products and connect with customers and healthcare professionals.”  commented Start Baillie, National Sales Manager.

 

The company will be presenting the new Robin EVO at the Innovations Theatre on 26 November, at 10.40am, afterwards visitors are invited to join the team on stand at their official launch for a product demonstration.

In addition to the official product launch, the company will hold a series of on stand product demonstrations throughout the event, which includes the Alber Scalamobil stair climber – an innovative mobility device that attaches to a wheelchair to help ascend or descend stairs, the award winning Maxxcare Heelboot with its pressure relieving properties and our highly popular Ocean Ergo Shower Chairs and Slings. 

Visitors to the stand can also pick up the latest resources and product information.

To pre-register for an on stand product demonstration, please email us at uk@invacare.com.
For more information visit our events page here: